A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
Description
The ASSERVO study is testing a potential medicine for infants to see if it may help prevent lower respiratory infections caused by RSV. Study participation includes 1 dose of the medicine or placebo, approximately 3 blood draws, e-diary entries, and nasal swabs collected during any respiratory illness.
MoreDetails
Age
Child
Eligibility
- 1 year old or younger - In good physical health
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Principal Investigator
Eric Simoes, MD
Study ID
Protocol Number: 21-3387
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers